This paper explores the revolutionary collaboration between artificial intelligence (AI) and nanotechnology in detecting and treating breast cancer. It highlights the synergistic potential of both fields to overcome significant limitations of modern approaches. Clinical applications and research demonstrate the diversity and depth of AI-based deep learning models in diagnostics, improving diagnostic accuracy and enabling precise, individualized therapy through advanced imaging and biomarker discovery. Through intelligent nanocarriers, nanotechnology contributes to these advancements by enabling targeted drug delivery, minimizing systemic toxicity, and providing theranostic capabilities for real-time monitoring. However, challenges remain, including data accessibility, model interpretability, scalability in nanocarrier manufacturing, and tumor diversity. Future improvements should focus on developing multifunctional nanoparticles, flexible AI algorithms, and scalable, cost-effective solutions to enhance accessibility and clinical integration. Hence, the study emphasizes the need for multidisciplinary collaboration to eliminate existing barriers and generate advancements to transform breast cancer therapies into more effective, safer, and individualized methods. Graphical Abstract

Polymeric ionic liquids (PILs) are interesting membrane materials for CO₂ separation. In order to increase the flexibility in tailoring the permeability and selectivity of PIL-based membranes for flue gas separation and natural gas purification, this work explores the use of PILs with mixtures of counter-anions employing a straightforward strategy. A new family of PIL random copolymers having pyrrolidinium cation pendant units combined with different counter-anion mixtures was synthesized and characterized. A simple and quantitative anion exchange procedure was successfully applied to the commercially available poly(diallyldimethylammonium) chloride as confirmed by NMR, FTIR and titration experiments. Composite membranes of the copolymers with 20 wt% of free ionic liquid ([pyr₁₄][NTf₂]) were prepared and their CO₂, CH₄ and N₂ permeation properties were measured at 20 °C using a time-lag apparatus. In addition, their tensile mechanical properties were also assessed. The results show that the permeability of all gases in the composite membranes is related to their gas diffusivities which are strongly dependent on the second counter-anion. The prepared membranes exhibit permselectivities ranging from 10.8 to 29.3 for CO₂/CH₄ and from 21.4 to 32.0 for CO₂/N₂. Furthermore, their CO₂ separation performance as a function of permeability can be tuned by using PILs with different counter-anion mixtures, which opens new possibilities for designing the CO₂ separation of these materials.

Despite progress in cancer treatments, it remains a leading cause of death worldwide. Current chemotherapy is often hampered by side effects, tissue damage, and drug resistance. To overcome these limitations, research is exploring new approaches to improve chemotherapy efficacy and reduce its side effects. A promising strategy involves combining chemotherapeutic drugs with phytochemicals, which are active compounds derived from plants. Nanotechnology plays a crucial role in delivering these often‐hydrophobic drugs, enhancing their bioavailability and solubility. This research area represents a significant convergence of nanotechnology with both conventional pharmaceuticals and botanical compounds. Global studies are increasingly demonstrating the potential of these combination therapies to inhibit cancer cell growth in laboratory and preclinical models. These studies suggest synergistic or additive effects that lead to improved treatment outcomes. This article focuses on recent advancements in nano‐drug delivery systems, specifically those designed for the simultaneous delivery of chemotherapeutic drugs and phytochemicals. It explores the selection of phytochemicals based on their anticancer properties, outlines the design considerations for nanocarriers, and discusses how physicochemical characteristics influence drug release kinetics. Additionally, the review examines nanoformulations that integrate synthetic drugs with natural components, highlighting the potential of herbal oils and medicines in cancer treatment.